Development and validation of the AURIS score for predicting candidaemia in Candidozyma auris-colonised patients in the intensive care unit: a bicentric retrospective cohort study

Key Points

• Candidaemia prediction is enhanced with the newly developed AURIS score, specifically for patients colonized with Candida auris.
• The AURIS score demonstrated a strong predictive value with a sensitivity of 85% and specificity of 90% in the studied population.
• This retrospective cohort analysis involved data from multiple centers, focusing on patients in intensive care units over a 12-month period.
• The findings highlight the potential for improved clinical decision-making and timely interventions in high-risk ICU settings.